Small cell lung cancer (SCLC) represents 20% of lung cancers and is characterized by early dissemination, development of chemoresistance and a poor prognosis. Small cell lung cancer (SCLC ... lead to the development of…
carcinoids, 32 of large cell neuroendocrine carcinomas and 60 of small cell lung cancer (SCLC). Analysis by immunohistochemistry for the following antigens was performed: estrogen receptor β (ERβ), ERα ... more than 60%…
Objective: Small cell lung cancer (SCLC) may be considered as a major health concern as a leading cause of cancer related mortality worldwide. Despite intensive management, SCLC may follow ... patients. Herein, we…
Lung cancer, mainly including small cell lung cancer (SCLC) and non-small lung cancer (non-SCLC, nSCLC), is a malignant and aggressive one and the leading cause of cancer-related ... molecules camptothecin, AP-3 and…
SCLC remains one of the most lethal lung cancers with limited therapeutic options. In recent years, we have made many advances on pathogenesis, heterogeneity and mechanism of resistance in SCLC ... Increasing studies…
Small cell lung cancer (SCLC) has typically high sensitivity to chemotherapy and radiotherapy, although greater part of patients with limited disease (LD) and all patients with extended disease (ED) will
Loss of FUS1 protein expression is found in almost all small cell lung cancer (SCLC) cell lines and tumor specimens. Therefore, restoration of normal FUS1 function by gene transfer could ... serve as a potential…
Small cell lung cancer (SCLC) requires very reliable markers for early identification. Evidence is mounting that extracellular vesicles convey tumour cell-specific cargo that could be used as cancer protein ... looked…
Purpose:This examine evaluates the clinical outcomes of substantial-stage small-cell lung cancer (SCLC) patients who received Irinotecan-based totally second-line chemotherapy after platinum-based first-line remedy…
Object: This study is to identify Small Cell Lung Cancer (SCLC) driver genes, annotate enrichment functions and key pathways, and also verify Monastrol therapeutic effect. Methods: The gene expression profiles…
Here, we demonstrate that CADM1 is also highly expressed in small cell lung cancer (SCLC) (4). Immunohistochemistry showed that 33 of 44 (75%) primary SCLC tumors expressed CADM1. Interestingly, SCLC ... common…
Objective: Small-Cell Lung Cancer (SCLC) constitutes about 15% of all lung cancers. It tends to frequently metastasize to the brain. Prophylactic Cranial Irradiation (PCI) is performed, when the penetration ... this…
explore the significance of serum ProGRP for diagnosis, monitor of small cell lung cancer (SCLC) and the relationship between ProGRP levels and prognosis of SCLC. Serum concentration of ProGRP ... subjects were detected…
Small Cell Lung Cancer (SCLC) is a multistage, aggressive, metastatic form of lung cancer that accounts for about 13% of all lung cancer cases, with a 5-year survival rate ... less than 6% mainly due to its metastatic…
cancer is the leading cause of death from cancer worldwide. Small cell lung cancer (SCLC) accounts for 15% to 20% of lung cancer. SCLC is characterized by a high rate ... invasion and rapid cell proliferation. The SCLC…
Small cell lung cancer (SCLC) is an aggressive disease, in which more than 80% of patients present distant metastases at the time of first diagnosis. Chemotherapy is considered ... main treatment of extensive disease of…
Background and objective: Small cell lung cancer (SCLC) is one of the most challenging tumors to treat due to high proliferation rate, early metastatic dissemination and rapid development of chemotherapy ... currently…
lung cancer including non-small cell lung cancer (NSCLC) and poor lung cell cancer (SCLC) are poor with a survival rate of less than 5%. The use of cell-oriented ... whose tumors undergo certain genetic mutations…
await current phase III trials to determine optimal radiation dose fractionation schemes in LS-SCLC, we report our experience in LS-SCLC with once daily HDRT. We hypothesized that HDRT ... therapy. Methods: We conducted…
toxicities, disease control and survival outcomes for limited disease small-cell lung cancer (LD-SCLC) treated with simultaneous integrated boost intensity-modulated radiation therapy (SIB-IMRT) versus conventional…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.